A dose-finding study of raltitrexed (tomudex) with cisplatin and epirubicin in advanced gastro-oesophageal adenocarcinoma

por Eatock, M M, Anthony, D A, El-Abassi, M, Wilson, P, Paul, J, Smith, M, Soukop, M, Evans, T R J
Publicado 2000

Phase II study of gemcitabine and cisplatin in locally advanced/metastatic oesophageal cancer

por Millar, J, Scullin, P, Morrison, A, McClory, B, Wall, L, Cameron, D, Philips, H, Price, A, Dunlop, D, Eatock, M
Publicado 2005

Multicentre phase II pharmacokinetic and pharmacodynamic study of OSI-7904L in previously untreated patients with advanced gastric or gastroesophageal junction adenocarcinoma

por Falk, S, Anthoney, A, Eatock, M, Van Cutsem, E, Chick, J, Glen, H, Valle, J W, Drolet, D W, Albert, D, Ferry, D, Ajani, J
Publicado 2006

A phase II study of capecitabine and oxaliplatin combination chemotherapy in patients with inoperable adenocarcinoma of the gall bladder or biliary tract

por Graham, J. S., Boyd, K., Coxon, F. Y., Wall, L. R., Eatock, M. M., Maughan, T. S., Highley, M., Soulis, E., Harden, S., Bützberger-Zimmerli, P., Evans, T. R. J.
Publicado 2016

A Phase I clinical study of cisplatin-incorporated polymeric micelles (NC-6004) in patients with solid tumours

por Plummer, R, Wilson, R H, Calvert, H, Boddy, A V, Griffin, M, Sludden, J, Tilby, M J, Eatock, M, Pearson, D G, Ottley, C J, Matsumura, Y, Kataoka, K, Nishiya, T
Publicado 2011